Vascular birthmarks

Vasa - Journal of Vascular Diseases

Volumn 37, Issue 1, 2008, Pages 5-17

  Willenberg, T ^a   Baumgartner, Iris ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Birthmarks; Hemangioma; Vascular malformations

Indexed keywords

ALPHA INTERFERON; CELL MARKER; CORTICOSTEROID; NEODYMIUM;

ANGIOGENESIS; ANGIOOSTEOHYPERTROPHY SYNDROME; ARTERIAL CIRCULATION; ARTERIOGRAPHY; ARTERIOVENOUS MALFORMATION; ARTIFICIAL EMBOLISM; CAPILLARY FLOW; CAPILLARY HEMANGIOMA; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL BLOOD VESSEL MALFORMATION; CONTRAST ENHANCEMENT; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ERBIUM YAG LASER; HEMANGIOMA; HEMANGIOMATOSIS; HEMODYNAMICS; HISTOPATHOLOGY; HUMAN; LOW LEVEL LASER THERAPY; LYMPH FLOW; LYMPHANGIOGENESIS; LYMPHANGIOGRAPHY; LYMPHATIC SYSTEM DISEASE; NEVUS FLAMMEUS; NUCLEAR MAGNETIC RESONANCE IMAGING; RENDU OSLER WEBER DISEASE; REVIEW; SCLEROTHERAPY; SEX DIFFERENCE; SURGICAL TECHNIQUE; SYMPTOM; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; YAG LASER;

COMBINED MODALITY THERAPY; HEMANGIOMA; HUMANS; INFANT; LYMPHATIC ABNORMALITIES; SKIN ABNORMALITIES; TREATMENT OUTCOME; VASCULAR MALFORMATIONS;

EID: 40349094698     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.37.1.5     Document Type: Review

References (56)

1. Albright AL, Gartner JC, Wiener ES. Lumbar cutaneous hemangiomas as indicators of tethered spinal cords. Pediatrics 1989 Jun; 83(6): 977-80.
2. Alomari AI, Karian VE, Lord DJ, Padua HM, Burrows PE. Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement. J Vasc Interv Radiol 2006 Oct; 17(10): 1639-48.
3. Bataille AC, Boon LM. Clinical aspects of capillary malformations. Ann Chir Plast Esthet 2006 Aug-Oct; 51(4-5): 347-56.
4. Benett ML, Fleischer AB Jr, Chamlin SL, Frieden IJ. Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol. 2001 Sep; 137(9): 1208-13.
5. Berwald C, Salazard B, Casanova D, Bardot J, Magalon G. Indications of lasers treatment for lymphatic malformations. Ann Chir Plast Esthet 2006 Aug-Oct; 51(4-5): 429-32.
6. Bouchard S, Yazbeck S, Lallier M. Perineal hemangioma, anorectal malformation, and genital anomaly: a new association. J Pediatr Surg 1999 Jul; 34(7): 1133-5.
7. Burrows PE, Mason KP. Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol 2004 May; 15(5): 431-45.
8. Chiller KG, Paasaro D, Frieden J. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol. 2002 Dec; 138(12): 1567-76.
9. Cho SK, Do YS, Shin SW, Kim DI, Kim YB, Park KB, Kim EJ, Ahn HJ, Choo SW, Choo IW. Arteriovenous malformations of the body and extremities: analysis of therapeutic outcomes and approaches according to a modified angiographic classification. J Endovasc Ther. 2006 Aug; 13(4): 527-38.
10. Cohen MM Jr. Vascular update: Morphogenesis, tumors, malformations and molecular dimensions. Am J Med Genet Part A 140A: 2013-38.
11. Colonna G, Ascencio G, Meunier L, Guillot B. Lymphangioma in a patient with Maffuci syndrome of the lower legs. J Mal Vasc 2002 Jun; 27(3): 174-6.
12. Delis KT, Gloviczki P, Wennberg PW, Rooke TW, Driscoll DJ. Hemodynamic impairment, venous segmental disease, and clinical severity scoring in limbs with Klippel-Trenaunay syndrome. J Vasc Surg 2007 Mar; 45(3): 561-7.
13. Dieterich-Miller CA, Safford PL. Psychosocial development of children with hemangiomas: home, school, health care collaboration. Child Health Care 1992 Spring; 21(2): 84-9.
14. Eifert S, Villavicencio JL, Kao TC, Taute BM, Rich NM. Prevalence of deep venous anomalies in congenital vascular malformations of venous predominance. J Vasc Surg 2000 Mar; 31(3): 462-71.
15. Elasa FJ, Lewis AR. Topical treatment of periocular capillary hemangioma. J Pediatr Ophthalmol Strabismus 1994 May-Jun; 31(3): 153-6.
16. Enjolras O, Mulliken JB, Boon LM, Wasef M, Kozakewich HP, Burrows PE. Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly. Plast Reconstr Surg 2001 Jun; 107(7): 1647-54.
17. Esterly NB, Margileth AM, Kahn G. Special symposia: the management of disseminated eruptive hemangioma in infants. Pediatr Dermatol 1984; 1: 312-7.
18. Ethunandan M, Mellor TK. Hemangiomas and vascular malformations of the maxillofacial region - a review. Br J Oral Maxillofac Surg 2006 Aug; 44(4): 263-72.
19. Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg 1983 Dec; 18(6): 894-900.
20. Frieden IJ, Reese V, Cohen ND. PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol 1996 Mar; 132(3): 307-11.
21. Holmdahl K. Cutaneous hemangiomas in premature and mature infants. Acta Paediatr 1955 Jul; 44(4): 370-9.
22. Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics 1976 Aug; 58(2): 218-22.
23. Katsinelos P, Chatzimavroudis G, Zavos C, Kamperis E, Triantafillidis I, Pilpilidis I, Katzinelos T, Papaziogas B. Gastric predominant hereditary hemorrhagic telangiectasia. Vasa 2006 Nov; 35(4): 258-61.
24. Kim YW, Lee BB, Cho JH, Do YS, Kim DI, Kim ES. Haemodynamic and clinical assessment of lateral marginal vein excision in patients with a predominantly venous malformation of the lower extremity. Eur J Vasc Endovasc Surg 2007 Jan; 33(1): 122-7.
25. Konez O, Burrows PE. An appropriate diagnostic workup for suspected vascular birthmarks. Cleve Clin J Med 2004 Jun; 71(6): 505-10.
26. Landthaler M, Hohenleutner U. Laser therapy of vascular lesions. Photodermatol Photoimmunol Photomed 2006 Dec; 22(6): 324-32.
27. Lee BB, Bergan JJ. Advanced management of congenital vascular malformations: a multidisciplinary approach. Cardiovasc Surg 2002 Dec; 10(6): 523-33.
28. Lee BB, Do YS, Yakes W, Kim DI, Mattassi R, Hyon WS. Management of arteriovenous malformations: a multidisciplinary approach. J Vasc Surg 2004 Mar; 39(3): 590-600.
29. Lee BB, Mattassi R, Kim BT, Kim YW, Ahn JM, Choi JY. Contemporary diagnosis and management of venous and arterio-venous shunting malformation by whole body blood pool scintigraphy. Int Angiol 2004 Dec; 23(4): 355-67.
30. Leon-Villapalos J, Wolfe K, Kangesu L. GLUT-1: an extra diagnostic tool to differentiate between hemangiomas and vascular malformations. Br J Plast Surg 2005 Apr; 58(3): 348-52.
31. Lyons LL, North PE, MacMoune Lay F, Stoller MH, Folpe AL, Weiss SW. Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol 2004 May; 28(5): 559-68.
32. Metry DW. Potential complications of segmental hemangiomas of infancy. Semin Cutan Med Surg 2004 Jun; 23(2): 107-15.
33. Mulliken JB, Enjolras O. Congenital hemangiomas and infantile hemangioma: missing links. J Am Acad Dermatol 2004 Jun; 50(6): 875-82.
34. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982 Mar; 69(3): 412-22.
35. Mulliken JB, Young EA. Vascular Birthmarks: Hemangiomas and Malformations. W. B. Saunders Company 1988: 24-37.
36. Mulliken JB, Young EA. Vascular Birthmarks: Hemangiomas and Malformations. W. B. Saunders Company 1988: 107-13.
37. Mulliken JB, Young EA. Vascular Birthmarks: Hemangiomas and Malformations. W. B. Saunders Company 1988: 170-95.
38. Mulliken JB, Young EA. Vascular Birthmarks: Hemangiomas and Malformations. W. B. Saunders Company 1988: 196-214.
39. Mulliken JB, Young EA. Vascular Birthmarks: Hemangiomas and Malformations. W. B. Saunders Company 1988: 215-27.
40. Mulliken JB, Young EA. Vascular Birthmarks: Hemangiomas and Malformations. W. B. Saunders Company 1988: 228-45.
41. Mulliken JB, Young EA. Vascular Birthmarks: Hemangiomas and Malformations. W. B. Saunders Company 1988: 246-74.
42. Noel AA, Gloviczki P, Cherry KJ, Rooke TW, Stanson AW, Discroll DJ. Surgical treatment of venous malformations in Klippel-Trenaunay syndrome. J Vasc Surg. 2000 Nov; 32(5): 840-7.
43. North PE, Waner M, Mizeracki A, Mrak RE, Nicholas R, Kincannon J, Suen JY, Mihm MC Jr. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 2001 May; 137(5): 559-70.
44. Puig S, Casati B, Staudenherz A, Paya K. Vascular low-flow malformations in children: current concepts for classification, diagnosis and therapy. Eur J Radiol 2005 Jan; 53(1): 35-45.
45. Ranchod TM, Frieden IJ, Fredrick DR. Corticosteroid treatment of periorbital hemangioma of infancy: a review of the evidence. Br J Ophthalmol 2005 Sep; 89(9): 1134-8.
46. Rupprecht R, Hundeicker M. Cutis marmorata teleangiectatica congenita. Important aspects for dermatologic practice. Hautarzt 1997 Jan; 48(1): 21-5.
47. Sadick H, Sadick M, Götte K, Naim R, Riedel F, Bran G, Hörmann K. Hereditary hemorrhagic telangiectasia: an update on clinical manifestations and diagnostic measures. Wien Klin Wochenschr 2006 Mar; 118(3-4): 72-80.
48. Salazard B, Londner J, Casanova D, Bardot J, Magalon G. The lymphatic malformations: clinical aspects and evolution. Ann Chir Plast Esthet 2006 Aug-Oct; 51(4-5): 412-22.
49. Schwarcz RM, Ben Simon GJ, Cook T, Goldberg RA. Sclerosing therapy as first line treatment for low flow vascular lesions of the orbit. Am J Ophthalmol 2006 Feb; 141(2): 333-9.
50. Serna MJ, Vasquez-Doval J, Vanaclocha V, Zubieta JL, Quintanilla E. Occult spinal dysraphism: a neurosurgical problem with a dermatologic hallmark. Pediatr Dermatol 1993 Jun; 10(2): 149-52.
51. Smolinski KN, Yan AC. Hemangiomas of Infancy: Clinical and Biological Characteristics. Clin Pediatr (Phila). 2005 Nov-Dec; 44(9): 747-66.
52. Takahashi K, et al. Cellular markers that distinguish the phases of hemangiomas during infancy and school. J Clin Inest 1994; 93(6): 2357-64.
53. Tan ST, Velickovic M, Ruger BM, Davis PF. Cellular and extracellular markers of hemangioma. Plast Reconstr Surg 2000 Sep; 106(3): 529-38.
54. Vermeer S, van Ostrom CG, Boetes C, Verrips A, Knoers NV. A unique case of PHACES syndrome confirming the assumption that PHACES syndrome and the sternal malformation-vascular dysplasia association are part of the same spectrum of malformations. Clin Dysmorphol 2005 Oct; 14(4): 203-6.
55. Waner M, North PE, Scherer KA, Frieden IJ, Waner A, Mihm MC Jr. The nonrandom distribution of facial hemangiomas. Arch Dermatol 2003 Jul; 139(7): 869-75.
56. Ziyeh S, Spreer J, Rössler J, Strecker R, Hochmuth A, Schumacher M, Klisch J. Parkes Weber or Klippel-Trenaunay syndrome? Non-invasive diagnosis with MR projection angiography. Eur Radiol 2004 Nov; 14(11): 2025-9.